- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: aromatase inhibitor
Total 67925 results
-
Jonsson Comprehensive Cancer CenterBayer; Translational Research in Oncology-U.S. Inc. (TRIO-US)TerminatedStage I Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative and other conditionsUnited States
-
UNICANCERNovartis; Fondation ARCCompletedMetastatic Breast CancerFrance
-
Indiana UniversityCompletedBreast Cancer | DCISUnited States
-
Massachusetts General HospitalNational Institute on Aging (NIA)Completed
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Dana-Farber Cancer InstitutePfizerCompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor (HR)-Positive Breast CancerUnited States
-
Imperial College LondonAstraZeneca; Cancer Research UKCompleted
-
Oncolytics BiotechSOLTI Breast Cancer Research GroupTerminated
-
Bristol-Myers SquibbCompletedCancer | Breast CancerBelgium, United States, Spain, France, Germany, Australia, Canada, Puerto Rico
-
Velindre NHS TrustAstraZeneca; Cardiff and Vale University Health Board; Covance; Cenduit LLCActive, not recruitingEstrogen Receptor Positive Breast CancerUnited Kingdom
-
Japan Breast Cancer Research GroupChugai PharmaceuticalCompletedMetastatic Breast CancerJapan
-
Erasme University HospitalActive, not recruiting
-
Shengjing HospitalActive, not recruiting
-
Novartis PharmaceuticalsTerminatedAdvanced or Metastatic ER+ Breast CancerUnited States, France, Germany, Singapore, Italy, Japan, Belgium
-
PfizerCompletedBreast CancerAustralia, India
-
Celcuity, Inc.Completed
-
China Medical University HospitalCompleted
-
PfizerActive, not recruitingAdvanced Breast CancerChina
-
Hoffmann-La RocheTerminatedBreast CancerItaly, United States, Korea, Republic of, Canada, Czechia, Spain, Australia, Bulgaria, China, Finland, France, Greece, Poland, Portugal, Taiwan, Thailand, Turkey, Colombia, Bosnia and Herzegovina, Mexico, Peru, Romania, Russian Federation and more
-
Zagazig UniversityActive, not recruitingGestational Trophoblastic DiseaseEgypt
-
PfizerActive, not recruitingMetastatic Breast CancerUnited States
-
Novartis PharmaceuticalsGlaxoSmithKlineCompletedNeoplasms, BreastBelgium, United Kingdom, Croatia, Hungary, Argentina, Australia, Germany, Israel, Japan, Poland, Russian Federation, Spain, France, Korea, Republic of, Hong Kong, United States, Brazil, Bulgaria, China, India, Ireland, Italy, Philip... and more
-
Syndax PharmaceuticalsCompleted
-
Universiti Kebangsaan Malaysia Medical CentreCompletedMiscarriage, RecurrentMalaysia
-
SanofiTerminatedBreast CancerFrance, Belgium, United States, Italy, Japan, Puerto Rico, Russian Federation, Spain, Ukraine
-
Hoffmann-La RocheCompletedEarly Breast CancerSpain, Korea, Republic of, Australia, Taiwan, Ukraine, Poland, Russian Federation, United States, Germany, Brazil, Hungary
-
Kyowa Kirin Co., Ltd.CompletedAdvanced or Recurrent Breast CancerJapan
-
Kyowa Kirin Co., Ltd.Completed
-
Gynuity Health ProjectsCompletedPregnancyUnited States
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenWithdrawn
-
Hospital Clinic of BarcelonaActive, not recruitingBreast Cancer | Genitourinary Syndrome of MenopauseSpain
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaTerminatedBreast Cancer | Hormone Receptor Positive TumorUnited States
-
University of Maryland, BaltimoreGenentech, Inc.TerminatedMetastatic Breast CancerUnited States
-
University Hospitals Cleveland Medical CenterWithdrawn
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
University of Maryland, BaltimoreSyndax PharmaceuticalsTerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Triple-negative Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Rahem Fertility CenterCompletedInfertility | Infertility, Female | Infertility, MaleEgypt
-
Wake Forest University Health SciencesCompletedOvarian Cysts | Ovulation DisorderUnited States
-
NSABP Foundation IncPfizer; Genomic Health®, Inc.CompletedBreast CancerUnited States, Canada
-
Eli Lilly and CompanyCompletedNon-Hodgkin's Lymphoma | Metastatic Cancer | Malignant Mesothelioma | Metastatic Breast Cancer | Non-small Cell Lung Cancer | Advanced CancerUnited States, Puerto Rico, Italy
-
Mansoura University HospitalCompleted
-
Emory UniversityNovartisTerminatedStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
PfizerCompletedBreast NeoplasmsSpain, Korea, Republic of, United States, Australia, Italy, Russian Federation
-
UNICANCERPfizer; NanoString Technologies, Inc.Completed
-
University of Colorado, DenverCompletedBreast Cancer | Stage II Breast Cancer | Stage III Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedMetastatic or Locally-advanced Unresectable Breast CancerUnited States
-
University of Maryland, BaltimoreGlaxoSmithKline; Novartis PharmaceuticalsTerminatedBreast Neoplasms | Neoplasm Metastasis | Endocrine Breast DiseasesUnited States
-
Boehringer IngelheimCompletedNeoplasmsSpain, Korea, Republic of, Belgium, Taiwan, United Kingdom, Austria, France, Netherlands, Ireland, Sweden
-
University Hospital, GhentCompleted
-
PfizerCompletedAdvanced Breast Cancer FemaleMexico, Argentina, Brazil, Colombia